Coregulation of Pathways in Lung Cancer Patients with EGFR Mutation: Therapeutic Opportunities

Scientists highlight regulatory mechanisms and signaling pathways that cause therapy-induced resistance to epidermal growth factor receptor tyrosine kinase inhibitors.